1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of Non-small Cell Lung Cancer (NSCLC) across the globe due to increasing air pollution and smoking habits
5.1.1.2. Presence of a strong pipeline for NSCLC therapeutics
5.1.2. Restraints
5.1.2.1. High cost and lack of availability of the drug
5.1.3. Opportunities
5.1.3.1. Introduction of new targeted therapies and treatments
5.1.3.2. Adoption of advanced therapeutics in the developing countries
5.1.4. Challenges
5.1.4.1. Capital intensive treatment and procedures
5.2. Cumulative Impact of COVID-19

6. Non-small Cell Lung Cancer Therapeutics Market, by Cancer Type
6.1. Introduction
6.2. Adenocarcinoma
6.3. Large Cell Carcinoma
6.4. Squamous Cell Carcinoma

7. Non-small Cell Lung Cancer Therapeutics Market, by Drug Class
7.1. Introduction
7.2. Angiogenesis Inhibitor
7.3. Epidermal Growth Factor Receptor Blocker
7.4. Folate Antimetabolites
7.5. Kinase Inhibitor
7.6. Microtubule Stabilizer
7.7. PD-1/ PD-L1 Inhibitor

8. Non-small Cell Lung Cancer Therapeutics Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies

9. Americas Non-small Cell Lung Cancer Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Non-small Cell Lung Cancer Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand

11. Europe, Middle East & Africa Non-small Cell Lung Cancer Therapeutics Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Astellas Pharma Inc
13.2. AstraZeneca PLC
13.3. Bristol Myers Squibb
13.4. C.H. Boehringer Sohn AG & Ko. KG
13.5. Celgene Corporation
13.6. Eisai Co., Ltd
13.7. Eli Lilly and Company
13.8. F. Hoffmann-La Roche Ltd
13.9. GlaxoSmithKline PLC
13.10. Merck KGaA
13.11. Novartis International AG
13.12. Orion Corporation
13.13. Pfizer Inc
13.14. Sanofi S.A.
13.15. Takeda Pharmaceutical Company Limited

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 3. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2020 VS 2027 (%)
FIGURE 4. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2020 VS 2027 (USD BILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2027
FIGURE 6. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY ADENOCARCINOMA, 2018-2027 (USD BILLION)
FIGURE 7. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 8. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY LARGE CELL CARCINOMA, 2018-2027 (USD BILLION)
FIGURE 9. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY LARGE CELL CARCINOMA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 10. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, 2018-2027 (USD BILLION)
FIGURE 11. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 12. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2027 (%)
FIGURE 13. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2027 (USD BILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2027
FIGURE 15. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY ANGIOGENESIS INHIBITOR, 2018-2027 (USD BILLION)
FIGURE 16. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY ANGIOGENESIS INHIBITOR, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY EPIDERMAL GROWTH FACTOR RECEPTOR BLOCKER, 2018-2027 (USD BILLION)
FIGURE 18. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY EPIDERMAL GROWTH FACTOR RECEPTOR BLOCKER, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY FOLATE ANTIMETABOLITES, 2018-2027 (USD BILLION)
FIGURE 20. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY FOLATE ANTIMETABOLITES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY KINASE INHIBITOR, 2018-2027 (USD BILLION)
FIGURE 22. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY KINASE INHIBITOR, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 23. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY MICROTUBULE STABILIZER, 2018-2027 (USD BILLION)
FIGURE 24. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY MICROTUBULE STABILIZER, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 25. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY PD-1/ PD-L1 INHIBITOR, 2018-2027 (USD BILLION)
FIGURE 26. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY PD-1/ PD-L1 INHIBITOR, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 27. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
FIGURE 28. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (USD BILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 30. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD BILLION)
FIGURE 31. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2027 (USD BILLION)
FIGURE 33. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2027 (USD BILLION)
FIGURE 35. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2020 VS 2027 (USD BILLION)
FIGURE 36. AMERICAS NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. ARGENTINA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 38. BRAZIL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. CANADA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 40. MEXICO NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. UNITED STATES NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 42. ASIA-PACIFIC NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 43. AUSTRALIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 44. CHINA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 45. INDIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 46. INDONESIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 47. JAPAN NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 48. MALAYSIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 49. PHILIPPINES NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 50. SINGAPORE NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 51. SOUTH KOREA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 52. TAIWAN NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 53. THAILAND NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 55. FRANCE NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 56. GERMANY NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 57. ITALY NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 58. NETHERLANDS NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 59. QATAR NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 60. RUSSIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 61. SAUDI ARABIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 62. SOUTH AFRICA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 63. SPAIN NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 64. UNITED ARAB EMIRATES NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 65. UNITED KINGDOM NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 66. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 67. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2027 (USD BILLION)
TABLE 4. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2018-2027 (USD BILLION)
TABLE 5. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY LARGE CELL CARCINOMA, BY REGION, 2018-2027 (USD BILLION)
TABLE 6. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2018-2027 (USD BILLION)
TABLE 7. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2027 (USD BILLION)
TABLE 8. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY ANGIOGENESIS INHIBITOR, BY REGION, 2018-2027 (USD BILLION)
TABLE 9. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY EPIDERMAL GROWTH FACTOR RECEPTOR BLOCKER, BY REGION, 2018-2027 (USD BILLION)
TABLE 10. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY FOLATE ANTIMETABOLITES, BY REGION, 2018-2027 (USD BILLION)
TABLE 11. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY KINASE INHIBITOR, BY REGION, 2018-2027 (USD BILLION)
TABLE 12. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY MICROTUBULE STABILIZER, BY REGION, 2018-2027 (USD BILLION)
TABLE 13. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY PD-1/ PD-L1 INHIBITOR, BY REGION, 2018-2027 (USD BILLION)
TABLE 14. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)
TABLE 15. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 16. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 17. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2027 (USD BILLION)
TABLE 18. AMERICAS NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 19. ARGENTINA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 20. BRAZIL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 21. CANADA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 22. MEXICO NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 23. UNITED STATES NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 24. ASIA-PACIFIC NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 25. AUSTRALIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 26. CHINA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 27. INDIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 28. INDONESIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 29. JAPAN NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 30. MALAYSIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 31. PHILIPPINES NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 32. SINGAPORE NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 33. SOUTH KOREA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 34. TAIWAN NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 35. THAILAND NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 37. FRANCE NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. GERMANY NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 39. ITALY NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 40. NETHERLANDS NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 41. QATAR NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 42. RUSSIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 43. SAUDI ARABIA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 44. SOUTH AFRICA NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 45. SPAIN NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 46. UNITED ARAB EMIRATES NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 47. UNITED KINGDOM NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 48. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: SCORES
TABLE 49. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 50. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 51. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: RANKING
TABLE 52. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 53. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 54. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 55. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 56. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 57. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 58. GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET: LICENSE & PRICING

Companies Mentioned

Astellas Pharma Inc
AstraZeneca PLC
Bristol Myers Squibb
C.H. Boehringer Sohn AG & Ko. KG
Celgene Corporation
Eisai Co., Ltd
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Merck KGaA
Novartis International AG
Orion Corporation
Pfizer Inc
Sanofi S.A.
Takeda Pharmaceutical Company Limited